Literature DB >> 17264076

Activation mechanism and steady state kinetics of Bruton's tyrosine kinase.

Marie Dinh1, Dorit Grunberger, Hoangdung Ho, Stan Y Tsing, David Shaw, Simon Lee, Jim Barnett, Ronald J Hill, David C Swinney, J Michael Bradshaw.   

Abstract

Bruton's tyrosine kinase (BTK) is a member of the Tec non-receptor tyrosine kinase family that is involved in regulating B cell proliferation. To better understand the enzymatic mechanism of the Tec family of kinases, the kinetics of BTK substrate phosphorylation were characterized using a radioactive enzyme assay. We first examined whether autophosphorylation regulates BTK activity. Western blotting with a phosphospecific antibody revealed that BTK rapidly autophosphorylates at Tyr(551) within its activation loop in vitro. Examination of a Y551F BTK mutant indicated that phosphorylation of Tyr(551) causes a 10-fold increase in BTK activity. We then proceeded to characterize the steady state kinetic mechanism of BTK. Varying the concentrations of ATP and S1 peptide (biotin-Aca-AAAEEIY-GEI-NH2) revealed that BTK employs a ternary complex mechanism with KmATP = 84 +/- 20 microM and KmS1 = 37 +/- 8 microM. Inhibition studies were also performed to examine the order of substrate binding. The inhibitors ADP and staurosporine were both found to be competitive with ATP and non-competitive with S1, indicating binding of ATP and S1 to BTK is either random or ordered with ATP binding first. Negative cooperativity was also found between the S1 and ATP binding sites. Unlike ATP site inhibitors, substrate analog inhibitors did not inhibit BTK at concentrations less than 1 mm, suggesting that BTK may employ a "substrate clamping" type of kinetic mechanism whereby the substrate Kd is weaker than Km. This investigation of BTK provides the first detailed kinetic characterization of a Tec family kinase.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17264076     DOI: 10.1074/jbc.M609920200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Insights into the conformational flexibility of Bruton's tyrosine kinase from multiple ligand complex structures.

Authors:  Andreas Kuglstatter; April Wong; Stan Tsing; Simon W Lee; Yan Lou; Armando G Villaseñor; J Michael Bradshaw; David Shaw; Jim W Barnett; Michelle F Browner
Journal:  Protein Sci       Date:  2011-02       Impact factor: 6.725

2.  Identification of an allosteric signaling network within Tec family kinases.

Authors:  Raji E Joseph; Qian Xie; Amy H Andreotti
Journal:  J Mol Biol       Date:  2010-09-06       Impact factor: 5.469

3.  Bruton's tyrosine kinase: from X-linked agammaglobulinemia toward targeted therapy for B-cell malignancies.

Authors:  Sabine Ponader; Jan A Burger
Journal:  J Clin Oncol       Date:  2014-04-28       Impact factor: 44.544

4.  Structures of human Bruton's tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases.

Authors:  Douglas J Marcotte; Yu-Ting Liu; Robert M Arduini; Catherine A Hession; Konrad Miatkowski; Craig P Wildes; Patrick F Cullen; Victor Hong; Brian T Hopkins; Elisabeth Mertsching; Tracy J Jenkins; Michael J Romanowski; Darren P Baker; Laura F Silvian
Journal:  Protein Sci       Date:  2010-03       Impact factor: 6.725

5.  Activation loop dynamics determine the different catalytic efficiencies of B cell- and T cell-specific tec kinases.

Authors:  Raji E Joseph; Iivari Kleino; Thomas E Wales; Qian Xie; D Bruce Fulton; John R Engen; Leslie J Berg; Amy H Andreotti
Journal:  Sci Signal       Date:  2013-08-27       Impact factor: 8.192

6.  Survey of phosphorylation near drug binding sites in the Protein Data Bank (PDB) and their effects.

Authors:  Kyle P Smith; Kathleen M Gifford; Joshua S Waitzman; Sarah E Rice
Journal:  Proteins       Date:  2014-11-18

7.  Physical and functional characterization of the genetic locus of IBtk, an inhibitor of Bruton's tyrosine kinase: evidence for three protein isoforms of IBtk.

Authors:  Carmen Spatuzza; Marco Schiavone; Emanuela Di Salle; Elzbieta Janda; Marco Sardiello; Giuseppe Fiume; Olga Fierro; Marco Simonetta; Notis Argiriou; Raffaella Faraonio; Rosanna Capparelli; Ileana Quinto; Giuseppe Scala
Journal:  Nucleic Acids Res       Date:  2008-07-02       Impact factor: 16.971

8.  A dynamically coupled allosteric network underlies binding cooperativity in Src kinase.

Authors:  Zachariah H Foda; Yibing Shan; Eric T Kim; David E Shaw; Markus A Seeliger
Journal:  Nat Commun       Date:  2015-01-20       Impact factor: 14.919

9.  Phenotypic Approaches to Identify Inhibitors of B Cell Activation.

Authors:  Elizabeth B Rex; Suzie Kim; Jake Wiener; Navin L Rao; Marcos E Milla; Daniel DiSepio
Journal:  J Biomol Screen       Date:  2015-05-06

10.  Pharmacological properties of JTE-052: a novel potent JAK inhibitor that suppresses various inflammatory responses in vitro and in vivo.

Authors:  Atsuo Tanimoto; Yoshihiro Ogawa; Chika Oki; Yukari Kimoto; Keisuke Nozawa; Wataru Amano; Satoru Noji; Makoto Shiozaki; Akira Matsuo; Yuichi Shinozaki; Mutsuyoshi Matsushita
Journal:  Inflamm Res       Date:  2014-11-12       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.